Mild To Moderate Erectile Dysfunction Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00137072|
Recruitment Status : Completed
First Posted : August 29, 2005
Last Update Posted : September 7, 2011
|Condition or disease||Intervention/treatment||Phase|
|Impotence||Drug: Viagra (Sildenafil Citrate) 100 mg||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||355 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study of Men With Mild to Moderate Erectile Dysfunction to Evaluate the Efficacy of Viagra 8 Hours Post-Dose|
|Study Start Date :||April 2005|
|Actual Study Completion Date :||February 2006|
- To determine the proportion of sexual intercourses that are successful in men with mild to moderate ED 8 hrs after a dose of Viagra.
- To determine the proportion of sexual intercourses that are successful in men with mild to moderate ED 12 hrs after a dose of Viagra. Other questionnaires such as SEP, IIEF.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00137072
Show 33 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|